FAIR principles for research software: a step forwards in discoverability
Familiarise yourself with the FAIR for Research Software principles, which aim to improve research transparency and reproducibility.
Evidence-based policy generation: how can we improve on open access?
Read about a proposed 5-part framework for strengthening the relationship between research and public policy.
Meeting report: summary of Day 2 of the 2023 ISMPP European Meeting
Missed the meeting? Read our report to get up to speed!
Are research data FAIR enough?
Find out why, despite implementation of mandates, current research data may not be FAIR.
Clear and present data: identifying barriers to clinical trial transparency
What’s standing in the way of researchers adopting good practices on clinical trial data sharing and transparency?
Data sharing and reporting still suboptimal in vaccine trials
A recent analysis of randomised controlled vaccine trials suggests there are still improvements to be made.
WHO mandates health-related data sharing
Learn all about the new WHO data sharing policy and their practical guidance on data sharing plans.
How common is data sharing for COVID-19 preprints?
An analysis of early COVID-19 preprints identified low uptake of data sharing statements and making data accessible.
The reality of data sharing behaviour: do researchers share their data as promised?
A recent study revealed that many researchers fail to comply with their data sharing statement.
NIH bid to tackle reproducibility crisis – is data sharing the answer?
Read about the upcoming NIH requirement to include a data management and sharing plan in all grant applications for projects collecting scientific data.
Are data availability statements slowing down publication processes?
Read the results of a pilot study on the impact of data availability statements on publication workflows.
WHO and ICMRA announce a joint statement on data transparency and integrity
Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
Open science is accelerated as a result of the COVID-19 pandemic
Find out how COVID-19 has benefited data sharing and what your organisation can do to advance open science from the State of Open Data 2020 report.
Acceleration of research and implications for research transparency: our summary of the third Biomedical Transparency Summit series webinar
The third webinar in the Biomedical Transparency Summit Series considered the impact of COVID-19 on research transparency and data sharing.
The future of data sharing: insights from PLOS’ Director, Open Research Solutions
Data sharing is crucial for reproducibility. Iain Hrynaszkiewicz shares his thoughts on how publishers can promote its uptake.
How research can be shared effectively to advance science: insights from the Center for Open Science
David Mellor from the Center for Open Science explains how the company is supporting and facilitating the open science movement.